About Index Trending news
Analyze
Top 50 Pricing
TESARO, Inc.

TESARO, Inc.

Work at TESARO, Inc.? Add yourself to this profile

TESARO, Inc.

TESARO is a biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Post-IPO equity
$50,000,000
Post-IPO equity
$155,000,000
Employees

Team size

50+
Locations
HQ
Headquarters
Xconomy

Tesaro Stock Sale Hauls in $409M on Heels of Strong Cancer Data